RAS GTPase inhibitor 1 (example 51) is a RAS GTPase inhibitor with anti-tumor activity, extracted from patent WO2018212774A1. RAS GTPase inhibitor 1 (example 51) exhibits an EC 50 less than 1 μM for at least one nucleotide exchange and an IC 50 less than 1 μM in H727 cells.